Corneal Cross-Linking: An Effective Treatment Option for Pellucid Marginal Degeneration

Area of Science:

• Ophthalmology
• Corneal Surgery
• Vision Science

Background:

• Pellucid marginal degeneration (PMD) is a progressive corneal ectasia.
• Management of PMD often involves corneal transplantation.
• Limited treatment options exist for halting PMD progression.

Purpose of the Study:

• To review the current literature on corneal cross-linking (CXL) for treating PMD.
• To assess the efficacy of CXL in managing PMD.
• To explore combined CXL and keratorefractive surgery for PMD.

Main Methods:

• Literature review of studies on CXL for PMD.
• Analysis of outcomes including visual stabilization and refractive changes.
• Evaluation of safety and efficacy of combined procedures.

Main Results:

• CXL demonstrates effectiveness in halting PMD progression and stabilizing vision.
• CXL may reduce or eliminate the need for corneal transplantation.
• Combined CXL and keratorefractive surgery is safe and improves vision in PMD patients.

Conclusions:

• CXL is a promising treatment for PMD, offering visual stabilization.
• Combined CXL and keratorefractive surgery shows potential for vision improvement.
• Further research with long-term follow-up is required to evaluate refractive outcomes.